
Disorders of sex development (DSD) include a heterogeneous group of heritable disorders of sex determination and differentiation, formerly termed "intersexuality". This includes chromosomal as well as monogenic disorders, which inhibit or change primarily genetic or endocrine pathways of normal sex development. However, in most patients affected, no definitive cause for the disorder can be found. Therefore, the birth of a child with ambiguous genitalia still represents an enormous challenge. For the structuring of diagnostic procedures, for decision making and also for therapeutic interventions a highly specialized team of physicians of different subspecialties and of experts for psychosocial care is needed to counsel parents and patients accordingly. This manuscript shall explain the genetic and molecular origins of DSD, the new DSD nomenclature, the consecutive classification and steps for diagnosis. New scientific topics on DSD are presented.
Germany, Practice Guidelines as Topic, Disorders of Sex Development, Humans, Genetic Predisposition to Disease, Practice Patterns, Physicians'
Germany, Practice Guidelines as Topic, Disorders of Sex Development, Humans, Genetic Predisposition to Disease, Practice Patterns, Physicians'
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
